FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Mats Ohlin

Research Profile

Concepts & Ideas

Genes & Molecular Sequences

Chemicals & Drugs

Living Beings

Physiology

Antibody Specificity

Phenomena

Protein Binding

Co-author Network

Publications

TOP 3
Mattias Levin; Mats Ohlin
Inconclusive Evidence for or against Positive Antigen Selection in the Shaping of Human Immunoglobulin E Repertoires: A Call for New Approaches.
Laura von Schantz; Björn Walse; Jacob Osterlin; Maria Håkansson; Derek T Logan; Eva Nordberg Karlsson; Mats Ohlin
Structural basis for carbohydrate-binding specificity--a comparative assessment of two engineered carbohydrate-binding modules.
Fredrika Carlsson; Franck Perez; Mirko Trilling; Mats Ohlin
A dimerized single-chain variable fragment system for the assessment of neutralizing activity of phage display-selected antibody fragments specific for cytomegalovirus.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Mats Ohlin (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Mattias Levin; Mats Ohlin
Inconclusive Evidence for or against Positive Antigen Selection in the Shaping of Human Immunoglobulin E Repertoires: A Call for New Approaches.
International archives of allergy and immunology 2013;161(2):122-6.
2012: Laura von Schantz; Björn Walse; Jacob Osterlin; Maria Håkansson; Derek T Logan; Eva Nordberg Karlsson; Mats Ohlin
Structural basis for carbohydrate-binding specificity--a comparative assessment of two engineered carbohydrate-binding modules.
Glycobiology 2012;22(7):948-61.
2012: Fredrika Carlsson; Franck Perez; Mirko Trilling; Mats Ohlin
A dimerized single-chain variable fragment system for the assessment of neutralizing activity of phage display-selected antibody fragments specific for cytomegalovirus.
Journal of immunological methods 2012;376(1-2):69-78.
2011: M Levin; L W Tan; L Baker; P-J Wormald; Lennart Greiff; Mats Ohlin
Diversity of immunoglobulin E-encoding transcripts in sinus mucosa of subjects diagnosed with non-allergic fungal eosinophilic sinusitis.
Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology 2011;41(6):811-20.
2010: Helena Persson; Jonas Persson; Lena Danielsson; Mats Ohlin
Charges drive selection of specific antibodies by phage display.
Journal of immunological methods 2010;353(1-2):24-30.
2009: Fredrika Axelsson; Jonas Persson; Emmanuel Moreau; Marie-Hélène Côté; Alain Lamarre; Mats Ohlin
Novel antibody specificities targeting glycoprotein B of cytomegalovirus identified by molecular library technology.
New biotechnology 2009;25(6):429-36.
2009: Per Augustsson; Jonas Persson; Simon Ekström; Mats Ohlin; Thomas Laurell
Decomplexing biofluids using microchip based acoustophoresis.
Lab on a chip 2009;9(6):810-8.
2009: Laura von Schantz; Fredrika Gullfot; Sebastian Scheer; Lada Filonova; Lavinia Cicortas Gunnarsson; James E Flint; Geoffrey Daniel; Eva Nordberg Karlsson; Harry Brumer; Mats Ohlin
Affinity maturation generates greatly improved xyloglucan-specific carbohydrate binding modules.
BMC biotechnology 2009;9():92.
2009: Jonas Persson; Martin Bäckström; Henrik Johansson; Karin Jirström; Gunnar Hansson; Mats Ohlin
Molecular evolution of specific human antibody against MUC1 mucin results in improved recognition of the antigen on tumor cells.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2009;30(4):221-31.
2009: Erika Gustafsson; Pieter-Jan Haas; Björn Walse; Marcel Hijnen; Christina Furebring; Mats Ohlin; Jos A G van Strijp; Kok P M van Kessel
Identification of conformational epitopes for human IgG on Chemotaxis inhibitory protein of Staphylococcus aureus.
BMC immunology 2009;10():13.
2008: Jonas Persson; Per Augustsson; Thomas Laurell; Mats Ohlin
Acoustic microfluidic chip technology to facilitate automation of phage display selection.
The FEBS journal 2008;275(22):5657-66.
2008: Kristina Lundberg; Malin Lindstedt; Kristina Larsson; Linda Dexlin; Christer Wingren; Mats Ohlin; Lennart Greiff; Carl A K Borrebaeck
Augmented Phl p 5-specific Th2 response after exposure of dendritic cells to allergen in complex with specific IgE compared to IgG1 and IgG4.
Clinical immunology (Orlando, Fla.) 2008;128(3):358-65.
2008: Helena Persson; Henrik Wallmark; Anne Ljungars; Johan Hallborn; Mats Ohlin
In vitro evolution of an antibody fragment population to find high-affinity hapten binders.
Protein engineering, design & selection : PEDS 2008;21(8):485-93.
2008: Helena Persson; Sabine Flicker; Mardjaneh Karbalaei Sadegh; Lennart Greiff; Rudolf Valenta; Mats Ohlin
A common idiotype in IgE and its relation to recognition of the grass pollen allergen Phl p 2.
Molecular immunology 2008;45(9):2715-20.
2007: Fredrika Axelsson; Stuart P Adler; Alain Lamarre; Mats Ohlin
Humoral immunity targeting site I of antigenic domain 2 of glycoprotein B upon immunization with different cytomegalovirus candidate vaccines.
Vaccine 2007;26(1):41-6.
2007: Helena Persson; Mardjaneh Karbalaei Sadegh; Lennart Greiff; Mats Ohlin
Delineating the specificity of an IgE-encoding transcriptome.
The Journal of allergy and clinical immunology 2007;120(5):1186-92.
2007: Lavinia Cicortas Gunnarsson; Cedric Montanier; Richard B Tunnicliffe; Michael P Williamson; Harry J Gilbert; Eva Nordberg Karlsson; Mats Ohlin
Novel xylan-binding properties of an engineered family 4 carbohydrate-binding module.
The Biochemical journal 2007;406(2):209-14.
2007: Helena Persson; Mats Ohlin
Exploring central and peripheral diversity in antibody evolution.
Molecular immunology 2007;44(10):2729-36.
2007: Yvelise Barrios; Susanne Knör; Johan Lantto; Michael Mach; Mats Ohlin
Clonal repertoire diversification of a neutralizing cytomegalovirus glycoprotein B-specific antibody results in variants with diverse anti-viral properties.
Molecular immunology 2007;44(5):680-90.
2007: Lada H Filonova; Lavinia Cicortas Gunnarsson; Geoffrey Daniel; Mats Ohlin
Synthetic xylan-binding modules for mapping of pulp fibres and wood sections.
BMC plant biology 2007;7():54.
2006: Lavinia Cicortas Gunnarsson; Qi Zhou; Cedric Montanier; Eva Nordberg Karlsson; Harry Brumer; Mats Ohlin
Engineered xyloglucan specificity in a carbohydrate-binding module.
Glycobiology 2006;16(12):1171-80.
2006: Jonas Persson; Mats Ohlin
Antigens for the selection of pan-variable number of tandem repeats motif-specific human antibodies against Mucin-1.
Journal of immunological methods 2006;316(1-2):116-24.
2006: Ulrika Andréasson; Sabine Flicker; Malin Lindstedt; Rudolf Valenta; Lennart Greiff; Magnus Korsgren; Carl A K Borrebaeck; Mats Ohlin
The human IgE-encoding transcriptome to assess antibody repertoires and repertoire evolution.
Journal of molecular biology 2006;362(2):212-27.
2006: Reine Johansson; Lavinia Cicortas Gunnarsson; Mats Ohlin; Sten Ohlson
Thermostable carbohydrate-binding modules in affinity chromatography.
Journal of molecular recognition : JMR 2006;19(4):275-81.
2006: Lavinia Cicortas Gunnarsson; Linda Dexlin; Eva Nordberg Karlsson; Olle Holst; Mats Ohlin
Evolution of a carbohydrate binding module into a protein-specific binder.
Biomolecular engineering 2006;23(2-3):111-7.
2006: Reine Johansson; Mats Ohlin; Bo Jansson; Sten Ohlson
Transiently binding antibody fragments against Lewis x and sialyl-Lewis x.
Journal of immunological methods 2006;312(1-2):20-6.
2006: Helena Persson; Johan Lantto; Mats Ohlin
A focused antibody library for improved hapten recognition.
Journal of molecular biology 2006;357(2):607-20.
2005: Jonas Persson; Johan Lantto; Torbjörn Drakenberg; Mats Ohlin
Subtle sequence differences in a tumour-associated peptide epitope translate into major changes in antigenicity.
Molecular immunology 2005;42(11):1321-30.
2004: Yvelise Barrios; Pernilla Jirholt; Mats Ohlin
Length of the antibody heavy chain complementarity determining region 3 as a specificity-determining factor.
Journal of molecular recognition : JMR 2004;17(4):332-8.
2004: Peter Ellmark; Mats Ohlin; Carl A K Borrebaeck; Christina Furebring
A novel mammalian display system for the selection of protein-protein interactions by decoy receptor engagement.
Journal of molecular recognition : JMR 2004;17(4):316-22.
2004: L Cicortas Gunnarsson; Eva Nordberg Karlsson; Ann-Sofie Albrekt; M Andersson; Olle Holst; Mats Ohlin
A carbohydrate binding module as a diversity-carrying scaffold.
Protein engineering, design & selection : PEDS 2004;17(3):213-21.
2003: Mats Ohlin; Moncef Zouali
The human antibody repertoire to infectious agents: implications for disease pathogenesis.
Molecular immunology 2003;40(1):1-11.
2003: Dorothee Gicklhorn; Markus Eickmann; Grit Meyer; Mats Ohlin; Klaus Radsak
Differential effects of glycoprotein B epitope-specific antibodies on human cytomegalovirus-induced cell-cell fusion.
The Journal of general virology 2003;84(Pt 7):1859-62.
2003: Johan Lantto; Jean M Fletcher; Mats Ohlin
Binding characteristics determine the neutralizing potential of antibody fragments specific for antigenic domain 2 on glycoprotein B of human cytomegalovirus.
Virology 2003;305(1):201-9.
2002: Carl A K Borrebaeck; Mats Ohlin
Antibody evolution beyond Nature.
Nature biotechnology 2002;20(12):1189-90.
2002: Johan Lantto; Mats Ohlin
Functional consequences of insertions and deletions in the complementarity-determining regions of human antibodies.
The Journal of biological chemistry 2002;277(47):45108-14.
2002: Peter Ellmark; Olga Esteban; Christina Furebring; Ann-Christin Malmborg Hager; Mats Ohlin
In vitro molecular evolution of antibody genes mimicking receptor revision.
Molecular immunology 2002;39(5-6):349-56.
2002: Johan Lantto; Jean M Fletcher; Mats Ohlin
A divalent antibody format is required for neutralization of human cytomegalovirus via antigenic domain 2 on glycoprotein B.
The Journal of general virology 2002;83(Pt 8):2001-5.
2002: Johan Lantto; Ylva Lindroth; Mats Ohlin
Non-germ-line encoded residues are critical for effective antibody recognition of a poorly immunogenic neutralization epitope on glycoprotein B of human cytomegalovirus.
European journal of immunology 2002;32(6):1659-69.
2002: Pernilla Jirholt; Carl A K Borrebaeck; Mats Ohlin
Antibody evolution from the centre to the periphery: applied to a human antibody fragment recognising the tumour-associated antigen mucin-1.
Journal of molecular biology 2002;318(2):407-16.
2002: Christina Furebring; Andrea Speckner; Michael Mach; Inger Sandlie; Lars Norderhaug; Carl A K Borrebaeck; Heléne Turesson; Mats Ohlin
Antibody-mediated neutralization of cytomegalovirus: modulation of efficacy induced through the IgG constant region.
Molecular immunology 2002;38(11):833-40.
2002: Johan Lantto; Mats Ohlin
Uneven distribution of repetitive trinucleotide motifs in human immunoglobulin heavy variable genes.
Journal of molecular evolution 2002;54(3):346-53.
2002: Johan Lantto; Pernilla Jirholt; Yvelise Barrios; Mats Ohlin
Chain shuffling to modify properties of recombinant immunoglobulins.
Methods in molecular biology (Clifton, N.J.) 2002;178():303-16.
2002: Ann-Christin Malmborg; Nina Nilsson; Mats Ohlin
Selection of antibodies based on antibody kinetic binding properties.
Methods in molecular biology (Clifton, N.J.) 2002;178():245-53.
2001: E Soderlind; Roland Carlsson; Carl A K Borrebaeck; Mats Ohlin
The immune diversity in a test tube--non-immunised antibody libraries and functional variability in defined protein scaffolds.
Combinatorial chemistry & high throughput screening 2001;4(5):409-16.
2001: Pernilla Jirholt; L Strandberg; Bo Jansson; Elias Krambovitis; Eskil Söderlind; Carl A K Borrebaeck; Roland Carlsson; L Danielsson; Mats Ohlin
A central core structure in an antibody variable domain determines antigen specificity.
Protein engineering 2001;14(1):67-74.
2000: Eskil Söderlind; L Strandberg; Pernilla Jirholt; N Kobayashi; V Alexeiva; A M Aberg; A Nilsson; Bo Jansson; Mats Ohlin; Christer Wingren; L Danielsson; Roland Carlsson; Carl A K Borrebaeck
Recombining germline-derived CDR sequences for creating diverse single-framework antibody libraries.
Nature biotechnology 2000;18(8):852-6.
1999: Andrea Speckner; D Glykofrydes; Mats Ohlin; Michael Mach
Antigenic domain 1 of human cytomegalovirus glycoprotein B induces a multitude of different antibodies which, when combined, results in incomplete virus neutralization.
The Journal of general virology 1999;80 ( Pt 8)():2183-91.
1999: Eskil Söderlind; Mats Ohlin; Roland Carlsson
Complementarity-determining region (CDR) implantation: a theme of recombination.
Immunotechnology : an international journal of immunological engineering 1999;4(3-4):279-85.
1998: Pernilla Jirholt; Mats Ohlin; Carl A K Borrebaeck; Eskil Söderlind
Exploiting sequence space: shuffling in vivo formed complementarity determining regions into a master framework.
Gene 1998;215(2):471-6.
1998: M Strandh; Mats Ohlin; C A Borrebaeck; Sten Ohlson
New approach to steroid separation based on a low affinity IgM antibody.
Journal of immunological methods 1998;214(1-2):73-9.
1998: Mats Ohlin; Carl A K Borrebaeck
Insertions and deletions in hypervariable loops of antibody heavy chains contribute to molecular diversity.
Molecular immunology 1998;35(4):233-8.
1998: Markus Eickmann; R Lange; Mats Ohlin; Marko Reschke; Klaus Radsak
Effect of cysteine substitutions on dimerization and interfragment linkage of human cytomegalovirus glycoprotein B (gp UL55).
Archives of virology 1998;143(10):1865-80.
1998: C Faber; Lin Shan; Z Fan; Luke W Guddat; Christina Furebring; Mats Ohlin; Carl A K Borrebaeck; Allen B Edmundson
Three-dimensional structure of a human Fab with high affinity for tetanus toxoid.
Immunotechnology : an international journal of immunological engineering 1998;3(4):253-70.
1997: Christina Furebring; Mats Ohlin; Sven Pettersson; Carl A K Borrebaeck
Evaluation of novel control elements by construction of eukaryotic expression vectors.
Gene 1997;188(2):191-8.
1997: Nina Nilsson; M Wallén-Ohman; Mats Ohlin; Carl A K Borrebaeck
Altered gene expression associated with apoptosis in a pre-B-leukemic cell line following cross-linking of MHC class I.
Experimental cell research 1997;231(1):190-7.
1997: Mats Ohlin; M Silvestri; V A Sundqvist; C A Borrebaeck
Cytomegalovirus glycoprotein B-specific antibody analysis using electrochemiluminescence detection-based techniques.
Clinical and diagnostic laboratory immunology 1997;4(1):107-11.
1996: A C Malmborg; M Dueñas; Mats Ohlin; Eskil Söderlind; Carl A K Borrebaeck
Selection of binders from phage displayed antibody libraries using the BIAcore biosensor.
Journal of immunological methods 1996;198(1):51-7.
1996: M Dueñas; L T Chin; A C Malmborg; R Casalvilla; Mats Ohlin; Carl A K Borrebaeck
In vitro immunization of naive human B cells yields high affinity immunoglobulin G antibodies as illustrated by phage display.
Immunology 1996;89(1):1-7.
1996: S Bold; Mats Ohlin; Wolfgang Garten; Klaus Radsak
Structural domains involved in human cytomegalovirus glycoprotein B-mediated cell-cell fusion.
The Journal of general virology 1996;77 ( Pt 9)():2297-302.
1996: Mats Ohlin; Carl A K Borrebaeck
Characteristics of human antibody repertoires following active immune responses in vivo.
Molecular immunology 1996;33(7-8):583-92.
1996: E Andersson; K Dahlenborg; Mats Ohlin; Carl A K Borrebaeck; Roland Carlsson
Immunoglobulin production induced by CD57+ GC-derived helper T cells in vitro requires addition of exogenous IL-2.
Cellular immunology 1996;169(2):166-73.
1996: Mats Ohlin; Carl A K Borrebaeck
Low affinity, antibody binding of an Escherichia coli-derived component.
FEMS immunology and medical microbiology 1996;13(2):161-8.
1996: M Dueñas; A C Malmborg; R Casalvilla; Mats Ohlin; Carl A K Borrebaeck
Selection of phage displayed antibodies based on kinetic constants.
Molecular immunology 1996;33(3):279-85.
1996: K Schoppel; E Hassfurther; W Britt; Mats Ohlin; C A Borrebaeck; Michael Mach
Antibodies specific for the antigenic domain 1 of glycoprotein B (gpUL55) of human cytomegalovirus bind to different substructures.
Virology 1996;216(1):133-45.
1996: Mats Ohlin; H Owman; Michael Mach; Carl A K Borrebaeck
Light chain shuffling of a high affinity antibody results in a drift in epitope recognition.
Molecular immunology 1996;33(1):47-56.
1995: J D Rioux; Bernard R Brodeur; Y Larose; Mats Ohlin; Carl A K Borrebaeck; Marianna M Newkirk
Generation of diversity in a human anti-viral response.
Annals of the New York Academy of Sciences 1995;764():381-3.
1995: C Wingren; U B Hansson; C G Magnusson; Mats Ohlin
Antigen-binding sites dominate the surface properties of IgG antibodies.
Molecular immunology 1995;32(11):819-27.
1995: E Andersson; Mats Ohlin; Carl A K Borrebaeck; Roland Carlsson
CD4+CD57+ T cells derived from peripheral blood do not support immunoglobulin production by B cells.
Cellular immunology 1995;163(2):245-53.
1995: M Dueñas; Marta Ayala; J Vázquez; Mats Ohlin; Eskil Söderlind; Carl A K Borrebaeck; Jorge V. Gavilondo
A point mutation in a murine immunoglobulin V-region strongly influences the antibody yield in Escherichia coli.
Gene 1995;158(1):61-6.
1995: Mats Ohlin; B Plachter; V A Sundqvist; P G Steenbakkers; Jaap Middeldorp; Carl A K Borrebaeck
Human antibody reactivity against the lower matrix protein (pp65) produced by cytomegalovirus.
Clinical and diagnostic laboratory immunology 1995;2(3):325-9.
1994: E Hardy; Mats Ohlin; M Llano
Enhanced ELISA sensitivity using TCA for efficient coating of biologically active lipopolysaccharides or lipid A to the solid phase.
Journal of immunological methods 1994;176(1):111-6.
1994: Mats Ohlin; H Owman; J D Rioux; Marianna M Newkirk; Carl A K Borrebaeck
Restricted variable region gene usage and possible rheumatoid factor relationship among human monoclonal antibodies specific for the AD-1 epitope on cytomegalovirus glycoprotein B.
Molecular immunology 1994;31(13):983-91.
1994: Mats Ohlin; Carl A K Borrebaeck
Flow cytometric analysis of the stability of antibody production by human x human x mouse heterohybridoma subclones.
Journal of immunological methods 1994;170(1):75-82.
1994: M Dueñas; J Vázquez; Marta Ayala; Eskil Söderlind; Mats Ohlin; L Pérez; Carl A K Borrebaeck; Jorge V. Gavilondo
Intra- and extracellular expression of an scFv antibody fragment in E. coli: effect of bacterial strains and pathway engineering using GroES/L chaperonins.
BioTechniques 1994;16(3):476-7, 480-3.
1994: L T Chin; Jorma Hinkula; M Levi; Mats Ohlin; Britta Wahren; Carl A K Borrebaeck
Site-directed primary in vitro immunization: production of HIV-1 neutralizing human monoclonal antibodies from lymphocytes obtained from seronegative donors.
Immunology 1994;81(3):428-34.
1993: C K Borrebaeck; A C Malmborg; Mats Ohlin
Does endogenous glycosylation prevent the use of mouse monoclonal antibodies as cancer therapeutics?
Immunology today 1993;14(10):477-9.
1993: P Ifversen; X M Zhang; Mats Ohlin; J Zeuthen; Carl A K Borrebaeck
Effect of cell-derived growth factors and cytokines on the clonal outgrowth of EBV-infected B cells and established lymphoblastoid cell lines.
Human antibodies and hybridomas 1993;4(3):115-23.
1993: Stefan Lundin; A Broeders; Mats Ohlin; K Hansson; Hans-Inge Bengtsson; J Trojnar; P Melin
Pharmacokinetic and pharmacologic properties of antiuterotonic oxytocin analogs in the rat.
The Journal of pharmacology and experimental therapeutics 1993;264(2):783-8.
1993: Mats Ohlin; V A Sundqvist; Michael Mach; Britta Wahren; Carl A K Borrebaeck
Fine specificity of the human immune response to the major neutralization epitopes expressed on cytomegalovirus gp58/116 (gB), as determined with human monoclonal antibodies.
Journal of virology 1993;67(2):703-10.
1992: M E Fernández de Cossío; Mats Ohlin; M Llano; B Selander; S Cruz; J del Valle; C A Borrebaeck
Human monoclonal antibodies against an epitope on the class 5c outer membrane protein common to many pathogenic strains of Neisseria meningitidis.
The Journal of infectious diseases 1992;166(6):1322-8.
1992: Mats Ohlin; K Kristensson; Roland Carlsson; Carl A K Borrebaeck
Epstein-Barr virus-induced transformation of human B lymphocytes: the effect of L-leucyl-L-leucine methyl ester on inhibitory T cell populations.
Immunology letters 1992;34(3):221-8.
1992: Mats Ohlin; Jorma Hinkula; P A Broliden; R Grunow; Carl A K Borrebaeck; Britta Wahren
Human MoAbs produced from normal, HIV-1-negative donors and specific for glycoprotein gp120 of the HIV-1 envelope.
Clinical and experimental immunology 1992;89(2):290-5.
1992: K Jönsson; K Alfredsson; C Söderberg-Ahlm; H Critchley; A Broeders; Mats Ohlin
Evaluation of the degradation of desamino1,D-arginine8-vasopressin by nasal mucosa.
Acta endocrinologica 1992;127(1):27-32.
1992: A C Malmborg; A Michaëlsson; Mats Ohlin; Bo Jansson; Carl A K Borrebaeck
Real time analysis of antibody-antigen reaction kinetics.
Scandinavian journal of immunology 1992;35(6):643-50.
1992: Carl A K Borrebaeck; A C Malmborg; Christina Furebring; A Michaelsson; S Ward; L Danielsson; Mats Ohlin
Kinetic analysis of recombinant antibody-antigen interactions: relation between structural domains and antigen binding.
Bio/technology (Nature Publishing Company) 1992;10(6):697-8.
1992: Roland Carlsson; C Mårtensson; S Kalliomäki; Mats Ohlin; Carl A K Borrebaeck
Human peripheral blood lymphocytes transplanted into SCID mice constitute an in vivo culture system exhibiting several parameters found in a normal humoral immune response and are a source of immunocytes for the production of human monoclonal antibodies.
Journal of immunology (Baltimore, Md. : 1950) 1992;148(4):1065-71.
1991: Stefan Lundin; N Pantzar; A Broeders; Mats Ohlin; Björn Weström
Differences in transport rate of oxytocin and vasopressin analogues across proximal and distal isolated segments of the small intestine of the rat.
Pharmaceutical research 1991;8(10):1274-80.
1991: L Danielsson; Christina Furebring; Mats Ohlin; L Hultman; M Abrahamson; Roland Carlsson; Carl A K Borrebaeck
Human monoclonal antibodies with different fine specificity for digoxin derivatives: cloning of heavy and light chain variable region sequences.
Immunology 1991;74(1):50-4.
1991: Eva Sjögren-Jansson; Mats Ohlin; C A Borrebaeck; Stig Jeansson
Production of human monoclonal antibodies in dialysis tubing.
Hybridoma 1991;10(3):411-9.
1991: Mats Ohlin; V A Sundqvist; G Gilljam; U Rudén; F O Gombert; Britta Wahren; Carl A K Borrebaeck
Characterization of human monoclonal antibodies directed against the pp65-kD matrix antigen of human cytomegalovirus.
Clinical and experimental immunology 1991;84(3):508-14.
1990: G Nilsson; P Lindblom; Mats Ohlin; R Berling; E Vernersson
Pharmacokinetics of terlipressin after single i.v. doses to healthy volunteers.
Drugs under experimental and clinical research 1990;16(6):307-14.
1990: M S Reid; Mario Herrera-Marschitz; Tomas Hökfelt; Mats Ohlin; K L Valentino; U Ungerstedt
Effects of intranigral substance P and neurokinin A on striatal dopamine release--I. Interactions with substance P antagonists.
Neuroscience 1990;36(3):643-58.
1990: B Beding-Barnekow; S Leander; Mats Ohlin; K Ninn-Pedersen; U Alkner; R Håkanson
Systemic and intraocular uptake of spantide, a tachykinin antagonist, following topical application to the rabbit eye.
Experimental eye research 1990;50(1):21-6.
1989: Mats Ohlin; P A Broliden; L Danielsson; B Wahren; J Rosen; Mikael Jondal; Carl A K Borrebaeck
Human monoclonal antibodies against a recombinant HIV envelope antigen produced by primary in vitro immunization. Characterization and epitope mapping.
Immunology 1989;68(3):325-31.
1989: A S Harris; Mats Ohlin; E Svensson; Stefan Lethagen; IM Nilsson
Effect of viscosity on the pharmacokinetics and biological response to intranasal desmopressin.
Journal of pharmaceutical sciences 1989;78(6):470-1.
1989: Mats Ohlin; L Danielsson; Roland Carlsson; Carl A K Borrebaeck
The effect of leucyl-leucine methyl ester on proliferation and Ig secretion of EBV-transformed human B lymphocytes.
Immunology 1989;66(4):485-90.
1988: A S Harris; Mats Ohlin; Stefan Lethagen; IM Nilsson
Effects of concentration and volume on nasal bioavailability and biological response to desmopressin.
Journal of pharmaceutical sciences 1988;77(4):337-9.
1988: Mats Ohlin; U Alkner
Development of an immunoassay for glypressin, an N-terminal extended vasopressin analogue.
Journal of immunoassay 1988;9(1):19-36.
1985: U B Hansson; Mats Ohlin; F D Lindström
IgG with a deviant conformation in serum and synovial fluid from rheumatoid arthritis patients.
Scandinavian journal of immunology 1985;22(1):27-32.
1982: P Hansson; S A Hedström; B Hultberg; Mats Ohlin
Fusidic acid interferes in enzymatic determination of bile acids.
Clinica chimica acta; international journal of clinical chemistry 1982;125(2):241-3.